椎体成形术市场 - 全球产业规模、份额、趋势、机会及预测（按产品、应用、适应症、最终用户、地区和竞争格局划分），2021-2031年

全球椎体成形术市场预计将从 2025 年的 7.3485 亿美元成长到 2031 年的 10.7285 亿美元，复合年增长率为 6.51%。

椎体成形术是一种微创技术，透过将一个特殊球囊插入骨折的椎体，形成一个空腔，然后注入骨水泥，以恢復椎体的高度和稳定性。市场成长的主要驱动力是全球人口老化导致的脊椎骨折发生率上升以及由此引发的骨质疏鬆症增加。此外，由于微创治疗方法具有住院时间短、恢復快等优势，人们越来越倾向于选择微创治疗而非传统开放性手术。

儘管有这些成长要素，但市场仍面临许多障碍，例如严格的报销通讯协定和高昂的手术费用，这限制了经济拮据的医疗机构中患者的就医途径。国际骨质疏鬆症基金会指出，到2024年，55岁及以上人口每年将发生多达3,700万例脆性骨折，凸显了骨折管理解决方案的巨大临床需求。然而，儘管发病率如此之高，但经济障碍和保险覆盖范围的限制仍然是限制市场更广泛发展和扩张的重大障碍。

市场驱动因素

椎体成形系统和骨水泥技术的进步显着推动了市场成长，提高了手术安全性和临床疗效。製造商正致力于研发高黏度骨水泥和先进的球囊导管，以确保精准恢復椎体高度，同时最大限度地降低渗漏风险，从而增强外科医生的信心并促进其应用。此外，射频靶向增强技术和可操控球囊的整合优化了手术流程，使这些微创手术比传统方法更具吸引力。史赛克公司2025年2月发布的报告也反映了这一需求，该报告指出，在专业脊椎技术的强劲应用推动下，该公司脊椎介入业务在2024年实现了超过10%的有机销售成长。

同时，骨质疏鬆症和椎体压迫性骨折的日益普遍，正成为全球市场扩张的潜在驱动力。随着人口老化，低骨骼密度现像日益普遍，导致易发生脆性骨折且需要手术固定的患者群体不断扩大。美国预防服务工作小组（USPSTF）在2025年1月指出，65岁以上女性中，骨质疏鬆症的盛行率为27.1%。这项数据与医疗机构优先考虑早期疗育导致的手术量增加趋势直接相关。这种需求促进了该行业的财务健康发展，Merit Medical Systems公司2024财年的年收入达到13.57亿美元，较上年增长7.9%，便印证了这一点。这项成长主要得益于该公司介入器材产品组合的强劲表现。

市场挑战

严格的报销政策和高昂的手术费用严重阻碍了椎体成形术市场的发展。医疗机构经常面临复杂的核准流程和椎体增强手术支付标准的下降，这在註重成本的医疗环境下阻碍了此类治疗方法的广泛应用。当保险覆盖范围受限或被拒绝时，经济负担往往会转移到医疗机构和患者身上，导致择期手术数量减少。这些经济压力迫使医院选择卧床休息和药物止痛等保守治疗，而非微创手术。

这些财务限制在各大医疗系统中尤为突出，直接影响脊椎专科手术的盈利和生存能力。 2024年，美国医学会（AMA）报告称，联邦医疗保险（Medicare）医生收费标准下调了3.39%，进一步压缩了开展椎体成形术的医疗机构的营运利润。此类财务限制使得医疗机构难以投资必要的设备，并降低了病患获得先进治疗的机会。因此，许多有效的临床适应症往往被转移到成本较低的疗法上，直接抑制了整体市场收入的成长。

市场趋势

脊椎增强手术向门诊手术中心 (ASC) 的转移，代表着一项由对高性价比门诊医疗服务的需求驱动的重大结构性变革。由于椎体成形术属于微创手术，支付方正积极推动将病例从传统医院转移到专科机构，以降低营运成本并提高病患处理效率。门诊手术中心的运作效率（更高的病例量和更快的出院流程）也支持了这一转变。 Surgery Partners, Inc. 正是这一趋势取得财务成功的典型例证。该公司于 2025 年 3 月公布，2024 财年营收达 31 亿美元（较上年增长 13.5%），并将这一增长归功于短期住院手术机构的战略扩张。

同时，术中三维透视和导航技术的引入，透过满足骨水泥注射过程中对精准度的关键需求，重新定义了手术标准。与标准的二维成像不同，这些先进系统能够即时、多维地可视化脊椎解剖结构，显着降低骨水泥渗漏的风险，并减少手术团队的辐射曝射量。这项技术的整合提高了临床医生对复杂骨折治疗的信心，并促进了增强疗法的更广泛应用。 2025年2月，Medtronic公布其颅脊椎技术部门的营收为12.5亿美元，年增3.8%，主要得益于公司底层技术生态系的强劲应用。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球椎体成形术市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（球囊导管、骨骼通路装置、骨水泥注射产品、骨水泥、骨水泥混合系统、器械）
  • 依应用领域（椎体矫正、脊椎骨折、脊椎后凸）
  • 依适应症（骨质疏鬆症、其他）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美椎体成形术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲椎体成形术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区椎体成形术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲椎体成形术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲椎体成形术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球椎体成形术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Stryker Corporation
• Medtronic plc
• Smith+Nephew Plc
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC（Halma plc）
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Kyphoplasty Market is projected to expand from USD 734.85 Million in 2025 to USD 1072.85 Million by 2031, reflecting a compound annual growth rate of 6.51%. Kyphoplasty involves a minimally invasive technique wherein a specialized balloon is inserted into a fractured vertebra to create a cavity, which is then filled with bone cement to restore height and stability. Market growth is primarily driven by a globally aging population and a corresponding rise in osteoporosis, which increases the incidence of spinal fractures. Additionally, the shift toward minimally invasive options over traditional open surgeries continues to gain traction due to advantages such as shorter hospital stays and accelerated recovery times.

Despite these growth drivers, the market encounters significant hurdles related to strict reimbursement protocols and the substantial costs of procedures, which limit patient access in economically constrained healthcare environments. The International Osteoporosis Foundation noted in 2024 that up to 37 million fragility fractures occur annually in individuals over the age of 55, underscoring a massive clinical need for fracture management solutions. However, even with this high incidence rate, financial barriers and coverage restrictions continue to pose significant obstacles to broader market development and expansion.

Market Driver

Technological advancements in kyphoplasty systems and bone cements are significantly propelling market growth by improving procedural safety and clinical results. Manufacturers are increasingly focusing on developing high-viscosity cements and advanced balloon catheters that minimize leakage risks while ensuring precise vertebral height restoration, thereby boosting surgeon confidence and adoption. Furthermore, the integration of radiofrequency-targeted augmentation and steerable balloons has optimized surgical workflows, making these minimally invasive interventions more appealing than traditional methods. This demand is reflected in Stryker's February 2025 report, which noted that their Interventional Spine business achieved over 10% organic sales growth in 2024, driven by the strong uptake of these specialized spine technologies.

Simultaneously, the rising prevalence of osteoporosis and vertebral compression fractures acts as a fundamental catalyst for global market expansion. As the population ages, low-bone-density conditions become more common, resulting in a larger pool of patients susceptible to fragility fractures that require surgical stabilization. The U.S. Preventive Services Task Force highlighted in January 2025 that osteoporosis affects 27.1% of women aged 65 and older, a statistic that correlates directly with increased procedural volumes as providers prioritize early intervention. This demand contributes to sector financial health, as evidenced by Merit Medical Systems reporting a 2024 annual revenue of $1.357 billion, a 7.9% year-over-year increase largely supported by its interventional device portfolio.

Market Challenge

Stringent reimbursement policies and high procedural costs constitute substantial barriers to the growth of the kyphoplasty market. Healthcare providers frequently face complicated approval processes and declining payment rates for vertebral augmentation, which discourages the widespread adoption of these treatments in cost-conscious settings. When insurance coverage is restricted or denied, the financial burden often shifts to medical facilities or patients, leading to a decline in elective procedure volumes. Consequently, economic pressures force hospitals to favor conservative management options, such as bed rest and pain medication, rather than utilizing minimally invasive surgical interventions.

These financial constraints are intensifying across major healthcare systems, directly impacting the profitability and viability of offering specialized spinal surgeries. In 2024, the American Medical Association reported a 3.39 percent reduction in Medicare physician payment rates, which further compresses operating margins for practices performing kyphoplasty. Such fiscal tightening limits the ability of healthcare providers to invest in necessary equipment and reduces patient access to advanced care. As a result, valid clinical candidates are often diverted toward lower-cost therapies, directly impeding total market revenue growth.

Market Trends

The migration of vertebral augmentation procedures to Ambulatory Surgical Centers (ASCs) represents a significant structural shift driven by the demand for cost-effective outpatient care. Because kyphoplasty is a minimally invasive procedure, payers are actively moving these cases from traditional hospitals to specialized facilities to lower overhead costs and improve patient throughput. This transition is supported by the operational efficiency of ASCs, which allow for higher case volumes and expedited discharge processes. The financial success of this trend is illustrated by Surgery Partners, which reported in March 2025 a total annual revenue of $3.1 billion for 2024, a 13.5% increase year-over-year attributed to the strategic expansion of short-stay surgical facilities.

Concurrently, the incorporation of intraoperative 3D fluoroscopy and navigation technologies is redefining procedural standards by addressing the critical need for precision during cement delivery. Unlike standard 2D imaging, these advanced systems provide real-time, multi-dimensional visualization of vertebral anatomy, significantly reducing the risk of cement leakage and lowering radiation exposure for the surgical team. This technological integration enhances clinical confidence in treating complex fractures, promoting broader utilization of augmentation therapies. In February 2025, Medtronic reported that its Cranial and Spinal Technologies division generated $1.25 billion in revenue, a 3.8% year-over-year increase driven primarily by the robust adoption of its enabling technology ecosystem.

Key Market Players

• Stryker Corporation
• Medtronic plc
• Smith + Nephew Plc
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC (Halma plc)
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

Report Scope

In this report, the Global Kyphoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kyphoplasty Market, By Product

• Balloon Catheters
• Bone Access Devices
• Cement Application Products
• Bone Cement
• Cement Mixing System
• Instruments

Kyphoplasty Market, By Application

• Vertebral Alignment Restoration
• Spinal Fractures
• Kyphosis

Kyphoplasty Market, By Indication

• Osteoporosis
• Others

Kyphoplasty Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Kyphoplasty Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kyphoplasty Market.

Available Customizations:

Global Kyphoplasty Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kyphoplasty Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing System, Instruments)
  • 5.2.2. By Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis)
  • 5.2.3. By Indication (Osteoporosis, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Kyphoplasty Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Indication
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Kyphoplasty Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Kyphoplasty Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Kyphoplasty Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By End User

7. Europe Kyphoplasty Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Indication
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Kyphoplasty Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By End User
  • 7.3.2. France Kyphoplasty Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Kyphoplasty Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Kyphoplasty Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Kyphoplasty Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By End User

8. Asia Pacific Kyphoplasty Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Indication
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Kyphoplasty Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By End User
  • 8.3.2. India Kyphoplasty Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Kyphoplasty Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Kyphoplasty Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Indication
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Kyphoplasty Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Indication
      • 8.3.5.2.4. By End User

9. Middle East & Africa Kyphoplasty Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Indication
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Kyphoplasty Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Kyphoplasty Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Kyphoplasty Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By End User

10. South America Kyphoplasty Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Indication
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Kyphoplasty Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Indication
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Kyphoplasty Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Indication
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Kyphoplasty Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Indication
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Kyphoplasty Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc
• 15.3. Smith + Nephew Plc
• 15.4. Microport Scientific Corporation
• 15.5. DePuy Synthes Companies
• 15.6. IZI Medical Products, LLC (Halma plc)
• 15.7. Merit Medical Systems, Inc.
• 15.8. Joline GmbH & Co. KG
• 15.9. Hensler Surgical Products LLC
• 15.10. Jiangsu Changmei Medtech Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer